Neoadjuvant PD-1 blockade combined with chemotherapy for patients with resectable locally advanced esophageal squamous cell carcinoma (ESCC): A real world data analysis

被引：4
|
作者：
Lv, H. [1 ]
Tian, Y. [2 ]
Huang, C. [1 ]
Sun, B. [1 ]
Gai, C. [1 ]
Li, Z. [1 ]
Tian, Z. [1 ]
机构：
[1] Fourth Hosp Hebei Med Univ, Dept Thorac Surg, Shijiazhuang, Hebei, Peoples R China
[2] Hangzhou Hosp Tradit Chinese Med, Dept Thorac & Cardiac Surg, Hangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.128
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
110P
引用
收藏
页码：S1423 / S1423
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma
    Cheng, Daoan
    Zhao, Weiqing
    Chen, Rui
    Li, Dong
    Tang, Shuxian
    Fang, Cheng
    Ji, Mei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [2] Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma
    Daoan Cheng
    Weiqing Zhao
    Rui Chen
    Dong Li
    Shuxian Tang
    Cheng Fang
    Mei Ji
    World Journal of Surgical Oncology, 21
  • [3] Neoadjuvant PD-1 blockade in combination with chemotherapy for patients with resectable esophageal squamous cell carcinoma
    Cheng Chao
    Yang Weixiong
    Chen Wenfang
    Yeung, Sau-Ching Jim
    Xing Xiangbin
    Wang Xiaoyan
    Bao Yong
    Feng Shiting
    Peng Fang
    Liu Zhenguo
    Zeng Bo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [4] Neoadjuvant durvalumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC)
    He, J.
    Zhao, L.
    Li, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S1553 - S1553
  • [5] Neoadjuvant PD-1 Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
    Qian, Ting
    Liu, Delin
    Cao, Guochun
    Chen, Zhipeng
    Zhang, Qin
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [6] Preoperative chemotherapy combined with PD-1 inhibitor in locally advanced operable or potentially resectable esophageal squamous cell carcinoma: A real world study.
    Wu, Puyuan
    Wang, Tao
    Chen, Baojun
    Shi, Minke
    Zhou, Yong
    Huang, Bin
    Wu, Nandie
    Qi, Liang
    Wang, Lifeng
    Wei, Jia
    Liu, Baorui
    Ren, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] A study of neoadjuvant sintilimab combined with chemotherapy TP for locally advanced esophageal squamous cell carcinoma (ESCC).
    Li, Zhao
    Xu, Peng-Fei
    Mao, Wei-Min
    Kuang, YuKang
    Fan, Hai-Yin
    Zou, Bin
    Zhu, Jian-Feng
    Li, Chao
    Cheng, Xiao-Liang
    Liu, Xing-Fei
    Guo, Changying
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16038 - E16038
  • [8] The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma
    Shen, Dijian
    Chen, Qixun
    Wu, Jie
    Li, Jianqiang
    Tao, Kaiyi
    Jiang, Youhua
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (01) : 1 - 10
  • [9] Neoadjuvant pembrolizumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim results.
    Wang, Weiwei
    Li, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16011 - E16011
  • [10] Neoadjuvant tislelizumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim analysis of a phase 2 study
    Zhuo, Na
    Qiu, Wei
    He, Jia
    Li, Li
    Wang, Qiang
    Yu, Shuangni
    Liu, Wei
    Zhao, Lin
    Bai, Chunmei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345